| Literature DB >> 24533190 |
Sandipani Sandilya1, Ladan Golestaneh1.
Abstract
We describe the case of a man who presented with back pain and acute kidney injury and was found to have bilateral ureteral obstruction, which initially corrected with ureteral stents. Imaging studies showed thickening of the bladder. Shortly thereafter, he developed obstructive jaundice, pancreatitis, recurrence of renal failure, and was diagnosed with advanced gastric cancer after a laparotomy revealed peritoneal carcinomatosis. The patient deteriorated rapidly after diagnosis. While peritoneal carcinomatosis, ureteral metastases, and extrinsic ureteral compression have been recognized in gastric cancer, obstructive renal failure due to tumor infiltration of the bladder wall is seldom described. We present this case as an unusual cause of acute renal failure and presentation of gastric cancer.Entities:
Year: 2011 PMID: 24533190 PMCID: PMC3914133 DOI: 10.1155/2011/387649
Source DB: PubMed Journal: Case Rep Nephrol ISSN: 2090-665X
Laboratory results from first hospitalization (normal values in parentheses).
| Hgb 10.2 (14–17.4 g/dL) | Na 136 (135–145 mEq/L) | Lipase 23 (10–195 U/L) | Urine Cr 232 mg/dL (20–370) |
| Hct 29.9 (40.1–50.4%) | K 5.4 (3.5–5.0 mEq/L) | Alb 3.3 (3.4–4.8 g/dL) | Urine Na 24 mEq/L |
| WBC 11.6 (4.8–10.8 k/ | BUN 58 (8–26 mg/dL) | Prot 5.8 (6.0–8.5 g/dL) | Urine K 45 mEq/L |
| PLT 208 (150–400 k/ | Cr 2.9 (0.5–1.5 mg/dL) | ALT 20 (5–40 U/L) | Urine Cl 13.3 mEq/L |
| TBILI 0.5 (0.2–1.2 mg/dL) | HC03 18 (24–30 mEq/L) | AST 16 (5–40 U/L) | |
| DBILI 0.3 (0.1–0.3 mg/dL) | Cl 105 (98–108 mEq/L) |
Urine Analysis: 21 WBCs, 18 RBCs, 100 protein, unremarkable cytology.
Figure 1A thickened bladder wall (arrowhead) with stranding of the mesenteric fat, status post-JJ stents. Despite the collapsed bladder, the wall thickening is clearly visible.
Admission laboratory results from second hospitalization (normal values in parentheses).
| Hgb 8.7 (14–17.4 g/dl) | Na 140 (135–145 mEq/L) | Lipase 577 (10–195 U/L) | Urine Na 24 mEq/L |
| Hct 26 (40.1–50.4%) | K 4.2 (3.5–5.0 mEq/L) | Alb 3.3 (3.4–4.8 g/dL) | Urine K 45 mEq/L |
| WBC 8.0 (4.8–10.8 k/ | BUN 12 (8–26 mg/dL) | Prot 6.5 (6.0–8.5 g/dL) | Urine Cl 13.3 mEq/L |
| PLT 200 (150–400 k/ | Cr 2.1 (0.5–1.5 mg.dL) | ALT 488 (5–40 U/L) | Urine Cr 232 (20–370 mg/dL) |
| TBILI 4.2 (0.2–1.2 mg/dL) | HCO3 18 (24–30 mEq/L) | AST 377 (5–40 U/L) | |
| DBILI 0.8 (0.1–0.3 mg/dL) | Cl 188 (98–108 mEq/L) | ALP 1046 (53–128 U/L) |
Urine analysis: WCC 18, RBC 100, positive for bacteria, eosinophils, and muddy brown casts.
Figure 2Images from our institution showing a thickened bladder wall (arrowhead on the right) and right-sided nephrosis (arrowhead on the left).
Figure 3Fibroadipose tissue with infiltrating poorly differentiated adenocarcinoma with signet-ring cell features (arrow), compatible with metastatic adenocarcinoma from known gastric adenocarcinoma.